Search Results - "MOTOO, Yoshiharu"

Refine Results
  1. 1

    Role of Kampo Medicine in Modern Cancer Therapy: Towards Completion of Standard Treatment by Motoo, Yoshiharu

    Published in Journal of Nippon Medical School (25-04-2022)
    “…Kampo Medicine is a traditional Japanese medicine and is well integrated with modern medicine. Anticancer agents are highly developed, and evidence regarding…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Prophylactic efficacy of ninjin’yoeito for oxaliplatin-induced cumulative peripheral neuropathy in patients with colorectal cancer receiving postoperative adjuvant chemotherapy: a randomized, open-label, phase 2 trial (HOPE-2) by Motoo, Yoshiharu, Tomita, Yasuto, Fujita, Hideto

    Published in International journal of clinical oncology (01-06-2020)
    “…Purpose Peripheral neuropathy (PN) is an intractable side effect of oxaliplatin, with no effective prophylaxis so far. Ninjin’yoeito (NYT), a Kampo medicine,…”
    Get full text
    Journal Article
  5. 5

    Kampo medicines for supportive care of patients with cancer: A brief review by Motoo, Yoshiharu, Cameron, Silke

    Published in Integrative medicine research (01-06-2022)
    “…Kampo medicines, which are standardized traditional Japanese herbal medicines, have been tried to support patients with cancer. Randomized controlled trials on…”
    Get full text
    Journal Article
  6. 6

    Generation and Accumulation of Various Advanced Glycation End-Products in Cardiomyocytes May Induce Cardiovascular Disease by Takata, Takanobu, Inoue, Shinya, Masauji, Togen, Miyazawa, Katsuhito, Motoo, Yoshiharu

    “…Cardiomyocyte dysfunction and cardiovascular diseases (CVDs) can be classified as ischemic or non-ischemic. We consider the induction of cardiac tissue…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Novel In Vitro Assay of the Effects of Kampo Medicines against Intra/Extracellular Advanced Glycation End-Products in Oral, Esophageal, and Gastric Epithelial Cells by Takata, Takanobu, Motoo, Yoshiharu

    Published in Metabolites (01-07-2023)
    “…Kampo medicines are Japanese traditional medicines developed from Chinese traditional medicines. The action mechanisms of the numerous known compounds have…”
    Get full text
    Journal Article
  9. 9

    Clinical practice guidelines for the management of olfactory dysfunction — Secondary publication by Miwa, Takaki, Ikeda, Katsuhisa, Ishibashi, Takuya, Kobayashi, Masayoshi, Kondo, Kenji, Matsuwaki, Yoshinori, Ogawa, Takao, Shiga, Hideaki, Suzuki, Motohiko, Tsuzuki, Kenzo, Furuta, Atsuko, Motoo, Yoshiharu, Fujieda, Shigeharu, Kurono, Yuichi

    Published in Auris, nasus, larynx (01-10-2019)
    “…To provide an evidence-based recommendation for the management of olfactory dysfunction in accordance with the consensus reached by the Subcommittee of the…”
    Get full text
    Journal Article
  10. 10

    Potential of the Novel Slot Blot Method with a PVDF Membrane for Protein Identification and Quantification in Kampo Medicines by Takata, Takanobu, Masauji, Togen, Motoo, Yoshiharu

    Published in Membranes (Basel) (01-12-2023)
    “…Kampo is a Japanese traditional medicine modified from traditional Chinese medicine. Kampo medicines contain various traditional crude drugs with unknown…”
    Get full text
    Journal Article
  11. 11

    Dual blockade of MET and VEGFR2 signaling pathways as a potential therapeutic maneuver for peritoneal carcinomatosis in scirrhous gastric cancer by Kasai, Suguru, Kuwayama, Naomi, Motoo, Yoshiharu, Kawashima, Atsuhiro, Matsumoto, Kunio, Yano, Seiji, Matsushima, Kouji, Yasumoto, Kazuo

    “…Scirrhous gastric cancer frequently develops into peritoneal carcinomatosis with malignant ascites, leading to an extremely poor prognosis. We had demonstrated…”
    Get full text
    Journal Article
  12. 12

    Analysis of Crude, Diverse, and Multiple Advanced Glycation End-Product Patterns May Be Important and Beneficial by Takata, Takanobu, Masauji, Togen, Motoo, Yoshiharu

    Published in Metabolites (19-12-2023)
    “…Lifestyle-related diseases (LSRDs), such as diabetes mellitus, cardiovascular disease, and nonalcoholic steatohepatitis, are a global crisis. Advanced…”
    Get full text
    Journal Article
  13. 13

    Review of the first 20 years of the Evidence‐Based Medicine Committee of the Japan Society for Oriental Medicine by Motoo, Yoshiharu, Arai, Ichiro, Kogure, Toshiaki, Tsutani, Kiichiro

    Published in Traditional & Kampo medicine (01-08-2021)
    “…ABSTRACT Objective/background The Evidence‐Based Medicine Special Committee of the Japan Society for Oriental Medicine was launched in 2001. We summarize the…”
    Get full text
    Journal Article
  14. 14

    Use of Kampo diagnosis in randomized controlled trials of Kampo products in Japan: a systematic review by Motoo, Yoshiharu, Arai, Ichiro, Tsutani, Kiichiro

    Published in PloS one (13-08-2014)
    “…The Committee for Evidence-based Medicine (EBM) of the Japan Society for Oriental Medicine started compiling Evidence Reports of Kampo Treatment (EKAT) in…”
    Get full text
    Journal Article
  15. 15

    How Long Should Cancer Chemotherapy Be Continued ?-From the Viewpoint of Duration of Efficacy of Molecular Targeting Drugs by Motoo, Yoshiharu

    Published in Gan to kagaku ryoho (01-07-2016)
    “…In cancer chemotherapy, some molecular targeting drugs maintain their efficacy even during a non-dosing period. Nivolumab, an anti-PD-1antibody that has…”
    Get more information
    Journal Article
  16. 16

    Pharmacists' perspectives on traditional, complementary, and integrative medicine in Japan with special reference to Kampo medicines: an internet survey with preliminary interviews by Motoo, Yoshiharu, Yukawa, Keiko, Hisamura, Kazuho, Arai, Ichiro

    “…Pharmacists guide patients in their use of traditional, complementary, and integrative medicine (TCIM). The present study aimed to evaluate the opinions of…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Effect of ninjin’yoeito and ginseng extracts on oxaliplatin-induced neuropathies in mice by Suzuki, Toshiaki, Yamamoto, Ayano, Ohsawa, Masahiro, Motoo, Yoshiharu, Mizukami, Hajime, Makino, Toshiaki

    Published in Journal of natural medicines (01-10-2017)
    “…Oxaliplatin (L-OHP) is a platinum-based anticancer agent used to treat various types of cancer. It frequently causes acute and chronic peripheral neuropathies,…”
    Get full text
    Journal Article
  19. 19

    Zonarol Protected Liver from Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease in a Mouse Model by Han, Jia, Guo, Xin, Koyama, Tomoyuki, Kawai, Daichi, Zhang, Jing, Yamaguchi, Reimon, Zhou, Xiaolei, Motoo, Yoshiharu, Satoh, Takumi, Yamada, Sohsuke

    Published in Nutrients (29-09-2021)
    “…Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases with no approved treatment. Zonarol, an extract from brown algae, has been…”
    Get full text
    Journal Article
  20. 20

    Physician perspectives on traditional, complementary, and integrative medicine and the national evidence-based Japanese integrative medicine information website: A mixed-method study by Motoo, Yoshiharu, Yukawa, Keiko, Hisamura, Kazuho, Arai, Ichiro

    Published in Integrative medicine research (01-03-2021)
    “…The evidence-based Japanese integrative medicine (eJIM) website was launched by the Japanese government in 2014 to provide information on integrative medicine…”
    Get full text
    Journal Article